Abeona Therapeutics (ABEO) Cost of Revenue (2020 - 2025)
Historic Cost of Revenue for Abeona Therapeutics (ABEO) over the last 8 years, with Q3 2025 value amounting to $488000.0.
- Abeona Therapeutics' Cost of Revenue changed N/A to $488000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $618000.0, marking a year-over-year change of. This contributed to the annual value of $1.6 million for FY2023, which is 25666.67% up from last year.
- As of Q3 2025, Abeona Therapeutics' Cost of Revenue stood at $488000.0.
- Over the past 5 years, Abeona Therapeutics' Cost of Revenue peaked at $32.9 million during Q1 2021, and registered a low of $30000.0 during Q3 2023.
- In the last 4 years, Abeona Therapeutics' Cost of Revenue had a median value of $350000.0 in 2022 and averaged $5.1 million.
- In the last 5 years, Abeona Therapeutics' Cost of Revenue changed by 0.0% in 2021 and then skyrocketed by 35000.0% in 2023.
- Abeona Therapeutics' Cost of Revenue (Quarter) stood at $32.9 million in 2021, then crashed by 99.7% to $100000.0 in 2022, then plummeted by 70.0% to $30000.0 in 2023, then skyrocketed by 1526.67% to $488000.0 in 2025.
- Its Cost of Revenue was $488000.0 in Q3 2025, compared to $100000.0 in Q2 2025 and $30000.0 in Q3 2023.